Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

NCT03138655 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis
Crohn's Disease

Interventions

DRUG: Vedolizumab

Sponsor

Takeda

Collaborators

[object Object]